Treatment of multidrug-resistant pulmonary TB: Standardized or individualized therapy?

2005, Number 4

Rev Inst Nal Enf Resp Mex 2005; 18 (4)

Miguel Salazar LMA

Language: Spanish
References: 6
Page: 337-338
PDF size: 32.20 Kb.

Text Extraction

No abstract

REFERENCES

Laniado-Laborín R. Tratamiento de la tuberculosis multifarmacorresistente, ¿esquema estandarizado o individualizado? Rev Inst Nal Enf Resp Mex 2005;18: 206-210.
Farmer P, Kim JY. Community based approaches to the control of multidrug resistant tuberculosis: introducing “DOTS-plus”. BMJ 1998;317:671-674.
Guidelines for the Management of Drug-Resistant Tuberculosis. In accordance with the WHO Green Light Committee for Access to Second-Line Anti-Tuberculosis Drugs. World Health Organization 2005 (en prensa).
Guía para la atención de pacientes con tuberculosis multifarmacorresistente. TAES-plus. Secretaría de Salud. Subsecretaría de Prevención y Promoción de la Salud. Centro Nacional de Vigilancia Epidemiológica y Control de Enfermedades. Diciembre, 2004.
Park SK, Lee WC, Lee DH, Mitnick CD, Han L, Seung KJ. Self-administered, standardized regimens for multidrug-resistant tuberculosis in South Korea. Int J Tuberc Lung Dis 2004;8:361-368.
DeRiemer K, Garcia-Garcia L, Bobadilla del Valle M, et al. Does DOTS work in populations with drug-resistant tuberculosis? Lancet 2005;365:1239-1245.